Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Evandro de Azambuja
Based on 110 articles published since 2010
(Why 110 articles?)
||||
Expertise Level
The expertise of Evandro de Azambuja ranks in the
  • Top 0.0062%
  • ... of 275,588 published authors worldwide on Breast Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 110 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases DE Azambuja, Evandro   ·   De Azambuja, E   ·   de Azambuja, Evandro   ·   De Azambuja, Evandro   ·   de Azambuja, E
Work Locations
Details
Most likely:    Jules Bordet Institute      
2020
  • Faculty of Medicine, American University of Beirut, Beirut, Lebanon. · Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Division of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Radiation Oncology, Institut Curie & Paris Sciences & Lettres, PSL University, Paris, France. · Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: · Pubmed 31654782
  • Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Vall D'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), 1000 Brussels, Belgium. · Department of Obstetrics and Gynecology, University of Ulm, 89081 Ulm, Germany. · Novartis Pharmaceutical, 4002 Basel, Switzerland. · SOLTI-Breast Cancer Research Group, 08035 Barcelona, Spain. · Breast International Group (BIG)-aisbl, 1000 Bruxelles, Belgium. · Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, 13125 Berlin, Germany. · Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511, USA. · Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, M4N 3M5 ON, Canada. · Groupe d'étude des facteurs pronostiques immunohistochimiques dans le cancer du sein, 75013 Unicancer, France. · Department of Pathology, The UT M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Pubmed 32085669
  • Clinical Trials Support Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium. · AC Camargo Cancer Center, São Paulo, Brazil. · Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy. · Department of Haematology, Oncology, Hemostasiology and Stem Cell Transplant (Medizinische Klinik IV), Uniklinik RWTH Aachen, Aachen, Germany. · CHU Saint-Pierre, Bruxelles, Belgium. · Clinical Trials Support Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium · Pubmed 32079624
  • Academic Promoting Team, Research Department, Institut Jules Bordet, Brussels, Belgium; AC Camargo Cancer Center, Sao Paulo, Brazil. · Statistical Department, Institut Jules Bordet, Brussels, Belgium. · Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Research Department, Institut Jules Bordet, Brussels, Belgium. · Academic Promoting Team, Research Department, Institut Jules Bordet, Brussels, Belgium. Electronic address: · Pubmed 31923729
  • Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. · AC Camargo Cancer Center, Sao Paulo, Brazil. · Frontier Science (Scotland), Kincraig, UK. · NRG Oncology, and The University of Pittsburgh Medical Center, Pittsburgh, PA, USA. · NRG Oncology, and the University of Pittsburgh, Pittsburgh, PA, USA. · IRCCS Ospedale Policlinico San Martino and University of Genova, GENOVA, Italy. · Mayo Clinic, Jacksonville, FL, USA. · Breast International Group (BIG), Brussels, Belgium. · Institut Regional du Cancer Montpellier Val d'Aurelle, Montpellier, France. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Bern, Bern, Switzerland. · Pubmed 31605311
2019
  • Department of Medical Oncology, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 30993330
  • Academic Trials Promoting Team. · Academic Trials Promoting Team; Medical Oncology Department, Institut Jules Bordet. Electronic address: · Pubmed 31928692
  • Department of Medical Oncology, Institut Jules Bordet, Bruxelles, Belgium. · Department of Medical Oncology, UOC Clinica di Oncologia Medica, Ospedale Policlinico San Martino, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Pubmed 31231572
  • Medical Support Team, Institut Jules Bordet, Brussels, Belgium. Electronic address: · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Medical Support Team, Institut Jules Bordet, Brussels, Belgium. · Pharmacy Department, Institut Jules Bordet, Brussels, Belgium. · Pubmed 31171494
  • Division of Early Drug Development, University of Milan, IRCCS European Institute of Oncology, Milan, Italy · Department of Medical Oncology, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium. · Cardio-Oncology Center of Excellence, Washington University, St. Louis, Missouri, USA. · Department of Anaesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cardioncology Unit, European Institute of Oncology, Milan, Italy. · Cardiology Division, European Institute of Oncology, Milan, Italy. · Pubmed 31064888
  • Institut Jules Bordet - Université Libre de Bruxelles (ULB); Medical Oncology Department, Academic Promoting Team at Boulevard de Waterloo, 121, 1000, Brussels, Belgium. · Pubmed 30938542
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Bruxelles, Belgium. · Pubmed 30833989
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Frontier Science, Kingussie, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · IEO, European Institute of Oncology IRCCS, University of Milan, Milan, Italy. · Mayo Clinic, Phoenix, AZ, USA. · Breast International Group, Brussels, Belgium. · National Cancer Institute, Bethesda, MD, USA. · Novartis Pharma AG, Basel, Switzerland. · Mayo Clinic, Jacksonville, FL, USA. · Sana Klinikum Offenbach, Offenbach, Germany. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Institut Gustave Roussy, Villejuif, France. · Champalimaud Clinical Center, Champalimaud Foundation and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain. · Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 31134488
  • Medical Oncology Department, Oncologisch Centrum, UZ Brussel, Brussels, Belgium. · Medical Oncology Department, AZ Sint-Lucas, Ghent, Belgium. · Medical Oncology Department, Imelda ziekenhuis, Bonheiden, Belgium. · Medical Oncology Department, CHU UCL Namur, Namur, Belgium. · Medical Oncology Department, Cliniques Sud-Luxembourg, Virton, Belgium. · Medical Oncology Department, Chwapi, Tournai, Belgium. · Medical Oncology Department, Oncologisch Centrum, UZ Brussel, Brussels, Belgium. · Medical Oncology Department, Institut Jules Bordet, L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of General Medical Oncology and Department of Oncology, University Hospitals Leuven, Louvain, Belgium. · Pubmed 31069589
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Frontier Science, Kingussie, U.K. · Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Klinik für Gynäkologie und Geburtshilfe, Interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Berlin, Germany. · Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, U.K. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Western General Hospital, University of Edinburgh Cancer Research Centre, Edinburgh, U.K. · Deakin University, Waurn Ponds, VIC, Australia. · Breast International Group (BIG), Brussels, Belgium. · F. Hoffmann-La Roche, Basel, Switzerland. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Harvard Medical School, Boston, MA, U.S.A. · Academic Department of Biochemistry, Royal Marsden Hospital, London, U.K. · Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, U.S.A. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 30711959
  • 1 Kantonsspital St Gallen, St Gallen, Switzerland. · 2 Dana-Farber Cancer Institute, Boston, MA. · 3 European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy. · 4 Rigshospitalet, Copenhagen, Denmark. · 5 Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium. · 6 KU Leuven, Leuven, Belgium. · 7 National Institute of Oncology, Budapest, Hungary. · 8 Lillebaelt Hospital, Vejle, Denmark. · 9 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France. · 10 Université de Bordeaux, Bordeaux, France. · 11 Auckland City Hospital, Auckland, New Zealand. · 12 CRO National Cancer Institute, Aviano, Italy. · 13 Ospedale Papa Giovanni XXIII, Bergamo, Italy. · 14 Ospedale Policlinico San Martino, Genoa, Italy. · 15 Centre de Cancérolgie Henri Becquerel, Rouen, France. · 16 ASST Spedali Civili di Brescia, Brescia, Italy. · 17 Ospedale Infermi di Rimini, AUSL della Romagna, Ravenna, Italy. · 18 Universitätsspital, Basel, Switzerland. · 19 Kantonsspital, Aarau, Switzerland. · 20 University Hospital Vaud University Hospital Center, Lausanne, Switzerland. · 21 Medical University of Gdansk, Gdansk, Poland. · 22 Hospital of Prato-AUSL Toscana Centro, Prato, Italy. · 23 Harvard Medical School, Boston, MA. · 24 Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA. · 25 University of Sydney, Sydney, NSW, Australia. · 26 International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 30475668
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, Université de Sherbrooke, Quebec, Canada. · Frontier Science, Kingussie, United Kingdom. · Breast International Group, Brussels, Belgium. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, Maryland. · Department of Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Rapid City Regional Hospital, Rapid City, South Dakota. · Breast Center, University of Ulm, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Jacksonville, Florida. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Harvard TH Chan School of Public Health, Boston, Massachusetts. · Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Pubmed 30335191
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kingussie, UK. · Breast Cancer Therapeutics, National Cancer Institute, Bethesda, MD. · Novartis Pharma AG, Basel, Switzerland. · Breast International Group, Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Policlinico San Martino-IRCCS per l'Oncologia, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada. · Johns Hopkins School of Medicine, Baltimore, MD. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · Department of Medicine, PUCRS, School of Medicine, Porto Alegre, Brazil. · Instituto Nacional de Câncer, Rio de Janeiro, Brazil. · Memorial Sloan Kettering Cancer Center, New York, NY. · Mayo Clinic, Jacksonville, FL. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA. · Pubmed 29878225
  • Instituto Nacional de Câncer and Clínica São Vicente, Rio de Janeiro, Brazil. Electronic address: · Frontier Science, Kincraig, United Kingdom. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Milan and European Institute of Oncology, Scientific Institute for Research, Hospitalization, and Healthcare, Milan, Italy. · The Breast International Group, Brussels, Belgium; Bristol-Myers Squibb, Princeton, NJ. · Roche Pharma, Bern, Switzerland. · The Breast International Group, Brussels, Belgium. · Breast European Adjuvant Study Team Data Center, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Roche Products, Welwyn Garden City, United Kingdom. · Genentech, South San Francisco, CA. · Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Harvard T.H. Chan School of Public Health, Boston, MA; Frontier Science and Technology Research Foundation, Boston, MA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Center Frankfurt Höchst, Frankfurt, Germany. · Pubmed 31924513
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy. · Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy. · Medical Oncology, Istituto Nazionale Tumori-IRCCS Fondazione Pascale, Naples, Italy. · La Sapienza University, Rome, Italy. · Department of Medical Oncology 1, Istituto Nazionale Tumori Regina Elena, Rome, Italy. · Department of Medical Oncology, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy. · Breast Unit, Azienda Ospedaliera Universitaria Città della Salute e delle Scienze, Torino, Italy. · Medical Oncology, Martini Hospital, ASL Città' di Torino, Italy. · Department of Medical Oncology, Hospital Businco, Cagliari, Italy. · Breast Unit, Medical Oncology, Azienda Ospedaliera S. Croce e Carle, Ospedale di Insegnamento, Cuneo, Italy. · Unit of Medical Oncology and Cancer Prevention, IRCCS Centro di Riferimento Oncologico Aviano-National Cancer Institute, Aviano (Udine), Italy. · Medical Oncology, Department of Medicine, University of Udine, Udine, Italy. · Day Hospital Oncologico Multidisciplinare, Istituto di Candiolo, FPO-IRCCS, Candiolo, Torino, Italy. · Pubmed 31724170
  • University of Ulm, Breast Center, Ulm, Germany. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Executive Vice President, Research & Development Oncology, AstraZeneca, United Kingdom. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Head of Breast Cancer Center, Department of Gynecology, Gynecologic Oncology and Obstetrics, HELIOS Klinikum Berlin, Buch, Germany. · Breast International Group, Brussels, Belgium. · Novartis Pharma AG, Oncology Development Unit, Basel, Switzerland. · Istenhegyi Gendiagnosztika Private Health Center, Oncology Clinic, Budapest, Hungary. · Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · KU Leuven - University of Leuven, Department of General Medical Oncology, University Hospitals Leuven, B-3000, Leuven, Belgium. · CRLCC Jean Godinot, Reims, France. · Marien-Hospital Witten, Witten, Germany. · Kidwai Memorial Institute of Oncology, Bangalore, India. · Hospital Doce de Octubre, Madrid, Spain. · Hospital Torrevieja-Salud, Torrevieja, Spain. · Krivoy Rog City Oncology Centre, Krivoy Rog, Ukraine. · Royal Bournemouth Hospital & Bournemouth University, Bournemouth, United Kingdom. · SOLTI - Breast Cancer Research Group, Barcelona, Spain. · Sana Klinikum Offenbach, Offenbach, Germany. · Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, USA. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Barcelona, Spain. · Pubmed 31377477
  • AC Camargo Cancer Center, Department of Medical Oncology, São Paulo, Brazil. · Institut Jules Bordet, Department of Research, Brussels, Belgium. · Pubmed 31341271
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Istitut Jules Bordet, Universitè Libre de Bruxelles, Belgium. · Breast International Group (BIG)-aisbl, Bruxelles, Belgium. · Yale Cancer Center, Yale School of Medicine, New Haven, USA. · Brustzentrum der Universität München (LMU), Munchen, Germany. · Oncology Clinical Development, Oncology Business Unit, Novartis Pharma AG, Basel, Switzerland. · Vall D'Hebron Institute of Oncology, Barcelona, Spain. · University of Ulm, Ulm, Germany. · IRCCS Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy. · Antonio Perrino Hospital, Brindisi, Italy. · IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri' Milano, Italy. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: · Pubmed 31284184
  • Frontier Science (Scotland), Kincraig, Kingussie. · Novartis Pharmaceuticals UK Limited, Frimley, UK. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA. · Medical Support Team of the Academic Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels. · Breast International Group (BIG), Brussels, Belgium. · Alliance for Clinical Trials in Oncology (formerly North Central Cancer Treatment Group), Mayo Clinic, Jacksonville. · AstraZeneca, Gaithersburg, USA. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Alliance Statistics and Data Center, Mayo Clinic, Scottsdale. · Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, USA. Electronic address: · Pubmed 31240310
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Fertility Clinic, CUB-Hôpital Erasme and Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 30847021
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Clinical Epidemiology Unit, Ospedale Policlinico San Martino, Genova, Italy. · Department of Medical Oncology, U.O. Oncologia Medica 2, Ospedale Policlinico San Martino, University of Genova, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Pubmed 30465156
2018
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 29636992
  • Department of Medical Oncology, Institut Jules Bordet, L'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino IRCCS per l'Oncologia, Genova, Italy. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, L'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29387483
  • Institut Jules Bordet, Blvd the Waterloo, Brussels, Belgium. · Institut Jules Bordet, Blvd the Waterloo, Brussels, Belgium. · Pubmed 29307195
  • Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. · Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Gynaecology and Obstetrics, Agaplesion Markus Hospital, Frankfurt am Main, Germany. · Division of Experimental Therapeutics, European Institute of Oncology, Milano, Italy. · German Breast Group, Neu-Isenburg, Germany. · Breast Center St. Gallen, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Medicine Department, Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 30167331
  • School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. · National Institute for Health Technology Assessment (IATS), Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · LACOG (Latin American Cooperative Oncology Group), Porto Alegre, Brazil. · Hospital do Câncer Mãe de Deus, Porto Alegre, Brazil. · University of Missouri, Columbia, SC, United States. · Department of Public Health Sciences, The University of Chicago, Chicago, IL, United States. · Harvard Medical School, Boston, MA, United States. · Massachusetts General Hospital, Boston, MA, United States. · Dana-Farber Cancer Institute, Boston, MA, United States. · Department of Radiology and Oncology, The State of Sao Paulo Cancer Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil. · CLION, CAM Group, Salvador, Brazil. · Department of Medical Oncology, Hospital São Lucas da PUCRS, Porto Alegre, Brazil. · Institut Jules Bordet and Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Innovation in Global Health, Department of Medicine, The University of Chicago, Chicago, IL, United States. · Pubmed 29872641
  • a Medical Department , Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B.) , Brussels , Belgium. · b Department of Medical Oncology , Oncologia Medica 2, Ospedale Policlinico San Martino IRCCS per l'Oncologia , Genova , Italy. · c Clinical Oncology Department , Hospital Santa Rita, Complexo Hospitalar Irmandade Santa Casa de Misericórdia de Porto Alegre; Rua Sarmento Leite , Porto Alegre , RS , Brazil. · Pubmed 29781317
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Leducuba, Universidade de Lisboa, Lisbon, Portugal. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: · Pubmed 29108713
  • Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Frontier Science Foundation-Hellas, Zografou, and National and Kapodistrian University of Athens, Athens, Greece. · Department of Surgery, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria. · The Royal Marsden Hospital, London, United Kingdom. · Oncology Biomarker Development, Genentech, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pathology Department, University Hospital "Fundacion Jimenez Diaz," Madrid, Spain. · University of Milan, European Institute of Oncology, Milan, Italy. · Department of Surgery, Kyoto University, Kyoto, Japan. · Breast Center, University of Munich (LMU), Munich, Germany. · Sunnybrook Odette Cancer Centre, Toronto Sunnybrook Regional Cancer Centre, Toronto, Canada. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Westmead Hospital, University of Sydney, Sydney, Australia. · Breast International Group (BIG), Brussels, Belgium. · Avera Cancer Institute, Sioux Falls, South Dakota. · Pubmed 29530933
  • Breast Cancer Research Laboratory, Department of Medicine, Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Blvd de Waterloo 121, Brussels, Belgium. · Frontier Science (Scotland) Ltd., Grampian View, Kingussie, PH21 1NA, UK. · MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Breast International Group, Boulevard de Waterloo 76, 1000, Brussels, Belgium. · Istituto Nazionale del Tumori, Via Giacomo Venezian, 1, 20133, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast Center, University of Ulm, Helmholtzstraße 16, 89081, Ulm, Germany. · Oncology Clinical Development, Oncology Business Unit, Novartis Pharma AG, Klybeckstrasse, 4057, Basel, Switzerland. · Institute for Oncology and Radiology of Serbia, National Cancer Research Center University of Belgrade, Pasterova 14, Belgrade, Serbia. · Brustzentrum, Frauenklinik der Universität München, Klinikum der Universität München, Maistraße 11, Munich, Germany. · Allgemeines Krankenhaus Celle, Siemenspl. 4, 29223, Celle, Germany. · Samsung Medical Center, 81 Irwon-ro, Irwon-dong, Gangnam-gu, Seoul, South Korea. · Hospital Virgen del Rocio, Avenida Manuel Siurot, S/N, 41013, Seville, Spain. · Changhua Christian Hospital, No. 176, Zhonghua Road, Changhua City, Changhua County, Taiwan, 500. · Mayo Clinic, 200 1st St SW, Rochester, MN, USA. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Freiburgstrasse 8, 3010, Bern, Switzerland. · Breast Cancer Research Laboratory, Department of Medicine, Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Blvd de Waterloo 121, Brussels, Belgium. · Pubmed 29280043
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Unité de Gestion de l'Information, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Medical Oncology Clinic, Charleroi Universitary Hospital, Université Libre de Bruxelles (U.L.B.), Charleroi, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 30425844
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium. · Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, centre affilié de l'Université de Sherbrooke, Quebec, Canada. · Department I of Internal Medicine, Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino, Department of Internal Medicine and Medical Specialties (DIMI), University of Genova, Genova, Italy. · Pubmed 29942664
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Computational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Center, East Melbourne, Victoria, Australia. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Obstetrics and Gynecology, University of Munich, Munich, Germany. · Novartis AG, Basel, Switzerland. · Department of Oncology, Istituto Nazionale Tumori, Milan, Italy. · Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany. · Breast Medical Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 29902299
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, Oncologia Medica 2, School of Medicine, University of Genova, Genova, Italy. · Unit of Clinical Epidemiology, School of Medicine, University of Genova, Genova, Italy. · Health Direction, School of Medicine, University of Genova, Genova, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino IRCCS per l'Oncologia, School of Medicine, University of Genova, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29873695
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Département d'hémato-oncologie, CISSS Montérégie-centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, Qc, Canada. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 29474991
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Breast Surgery, University Hospital Herlev, Copenhagen, Denmark. · Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Vall D'Hebron University Hospital, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · Macerata Hospital, Macerata, Italy. · Danish Breast Cancer Group, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group Statistical Centre, Dana-Farber Cancer Institute, Boston, MA. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · European Institute of Oncology, Milan, Italy. · Pubmed 29087485
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Fertility Clinic, CUB-Hôpital Erasme and Research Laboratory on Human Reproduction, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universiade de Lisboa, Lisbon, Portugal. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · Medical Genetics Department, CUB-Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29045555
2017
  • Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany. · Département d'Hémato-Oncologie, Hopital Charles-Lemoyne, Greenfield Par, Quebec, Canada. · Pubmed 28761736
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. · Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Medical Support Team of the Academic Promoting Team (APT), Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Pubmed 28762384
  • Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. · Department of Medical Oncology and IRON/U1245, Centre Henri Becquerel, Rouen, France. · Breast Cancer Translational Research Laboratory. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 28744140
  • a Clinique d'Oncologie Médicale, Institut Jules Bordet , Université Libre de Bruxelles (U.LB) , Brussels , Belgium. · b Département d'hémato-oncologie , CISSS Montérégie centre/Hôpital Charles Lemoyne, centre affilié de l'Université de Sherbrooke , Greenfield Park , Qc , Canada. · c Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University of Cologne , Cologne , Germany. · d Breast Cancer Translational Research Laboratory, Institut Jules Bordet , Université Libre de Bruxelles (U.L.B) , Brussels , Belgium. · Pubmed 28697311
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Molecular Immunology Unit, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 28185173
  • a BrEAST Data Centre, Institut Jules Bordet , l'Université Libre de Bruxelles (U.L.B.) , Brussels , Belgium. · b Breast Cancer Translational Research Laboratory , Institut Jules Bordet , Brussels , Belgium. · c Molecular Immunology Unit , Institut Jules Bordet , Brussels , Belgium. · Pubmed 27883296
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Dimitrios Zardavas, Breast International Group · Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Thomas M. Suter, Bern University Hospital, Bern · Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland · and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. · Pubmed 28199174
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • Department of Medicine I , Medical University of Vienna , Vienna , Austria. · Department of Medical Oncology , Institut Jules Bordet , Brussels , Belgium. · Pubmed 27900209
  • BrEAST Data Center, Institut Jules Bordet , Brussels , Belgium. · BrEAST Data Center, Institut Jules Bordet, Brussels, Belgium; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Genova, Italy. · Pubmed 27843627
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Department of Medical and Biological Sciences, University of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Oncology, University Hospital of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven-University of Leuven, B-3000 Leuven, Belgium. · Department of Pathology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of General Medical Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Gynecology and Obstetrics, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Pubmed 27802449
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology and Breast Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. · Pubmed 26654400
  • Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Liverpool and Merseyside Academic Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, UK. · Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Oncology, West Middlesex University Hospital, London, UK. · Department of Clinical Oncology, The Royal United Hospital, Combe Park, Bath, UK. · Ealing Hospital NHS Trust, Middlesex, UK. · Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK. · University of Manchester, Institute of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Pubmed 26334099
2015
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Hôpital Ambroise Pare, Mons, Belgium. · Neuropsychologue CHIREC, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cardiology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, Liege, Belgium. · Department of Oncology, CHU Tivoli - GOHH, La Louviere, Belgium. · Clinique Ste-Elisabeth, Namur, Belgium. · Department of Oncology, Hôpital de Jolimont, Haine St Paul, Belgium. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland. · Pubmed 26321502
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands · Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology · Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain · Holger Eidtmann, University Hospital Kiel, Kiel · Nadia Harbeck, University of Munich, Munich, Germany · Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom · Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles · Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium · Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Catherine Ellis, GlaxoSmithKline, Collegeville, PA · and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • Ciara C. O'Sullivan and Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Ian Bradbury, Christine Campbell, and Eileen Holmes, Frontier Science, Inverness-shire, Scotland · Marc Spielmann and Suzette Delaloge, Institut de Cancérologie Gustave Roussy, Villejuif, France · Edith A. Perez, Mayo Clinic, Jacksonville, FL · Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland · Joseph P. Costantino and Priya Rastogi, University of Pittsburgh, Pittsburgh, PA · Dimitrios Zardavas, Breast International Group · Karla V. Ballman, Mayo Clinic, Rochester, MN · Evandro de Azambuja and Martine Piccart-Gebhart, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium · and Richard D. Gelber, Harvard Medical School, Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA. · Pubmed 26101239
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25899784
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles · Dimitrios Zardavas, Breast International Group, Brussels, Belgium · Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia · and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 24794210
  • Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Istituto Nazionale del Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Spain. · GlaxoSmithKline, Collegeville, PA, USA. · Clinic for Gynaecology, Gynaecologic Oncology and Obstetrics and Breast Cancer Centre, HELIOS Klinikum Berlin, Buch, Germany. · Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, NSW, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · PUC-RS School of Medicine, Porto Alegre, Brazil. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Kliniken Essen-Mitte, Essen, Germany. · National Taiwan University Hospital, Taipei, Taiwan. · Clinique St-Elisabeth, Namur, Belgium. · Mackay Memorial Hospital, Taipei, Taiwan. · Kashirskoye Shosse, Moscow, Russia. · Cancer Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania. · Department of Medical Oncology, University of Pretoria, Pretoria, South Africa. · Odessa Oncology Centre, Odessa, Ukraine. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Kiel, Kiel, Germany. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25130998
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. Electronic address: · Department of Medical Oncology and Breast Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. · Pubmed 25156453
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
  • Department of Medical Oncology, Institut Jules Bordet, Brussels. · Data Centre, Institut Jules Bordet, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Brussels · Pubmed 24562450
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium ; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Brussels, Belgium. · Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Pubmed 24415979
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
2013
  • Medical Oncology Department, Institut Jules Bordet, Br.E.A.S.T. Data Centre Brussels, Blvd de Waterloo, 121 (7th Floor), 1000 Brussels, Belgium. · Pubmed 24138446
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Boulevard de Waterloo, 121 (7th floor), 1000 Brussels, Belgium. · Pubmed 24074778
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Blvd de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23341518
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Pubmed 24078620
  • Breast International Group, Brussels, Belgium; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23643661
Probable:    Universite Libre de Bruxelles      
2020
  • Clinical Trials Support Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium. · AC Camargo Cancer Center, São Paulo, Brazil. · Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy. · Department of Haematology, Oncology, Hemostasiology and Stem Cell Transplant (Medizinische Klinik IV), Uniklinik RWTH Aachen, Aachen, Germany. · CHU Saint-Pierre, Bruxelles, Belgium. · Clinical Trials Support Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium · Pubmed 32079624
  • Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. · AC Camargo Cancer Center, Sao Paulo, Brazil. · Frontier Science (Scotland), Kincraig, UK. · NRG Oncology, and The University of Pittsburgh Medical Center, Pittsburgh, PA, USA. · NRG Oncology, and the University of Pittsburgh, Pittsburgh, PA, USA. · IRCCS Ospedale Policlinico San Martino and University of Genova, GENOVA, Italy. · Mayo Clinic, Jacksonville, FL, USA. · Breast International Group (BIG), Brussels, Belgium. · Institut Regional du Cancer Montpellier Val d'Aurelle, Montpellier, France. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Bern, Bern, Switzerland. · Pubmed 31605311
2019
  • Institut Jules Bordet - Université Libre de Bruxelles (ULB); Medical Oncology Department, Academic Promoting Team at Boulevard de Waterloo, 121, 1000, Brussels, Belgium. · Pubmed 30938542
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Bruxelles, Belgium. · Pubmed 30833989
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Frontier Science, Kingussie, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · IEO, European Institute of Oncology IRCCS, University of Milan, Milan, Italy. · Mayo Clinic, Phoenix, AZ, USA. · Breast International Group, Brussels, Belgium. · National Cancer Institute, Bethesda, MD, USA. · Novartis Pharma AG, Basel, Switzerland. · Mayo Clinic, Jacksonville, FL, USA. · Sana Klinikum Offenbach, Offenbach, Germany. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Institut Gustave Roussy, Villejuif, France. · Champalimaud Clinical Center, Champalimaud Foundation and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain. · Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 31134488
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Frontier Science, Kingussie, U.K. · Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Klinik für Gynäkologie und Geburtshilfe, Interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Berlin, Germany. · Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, U.K. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Western General Hospital, University of Edinburgh Cancer Research Centre, Edinburgh, U.K. · Deakin University, Waurn Ponds, VIC, Australia. · Breast International Group (BIG), Brussels, Belgium. · F. Hoffmann-La Roche, Basel, Switzerland. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Harvard Medical School, Boston, MA, U.S.A. · Academic Department of Biochemistry, Royal Marsden Hospital, London, U.K. · Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, U.S.A. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 30711959
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, Université de Sherbrooke, Quebec, Canada. · Frontier Science, Kingussie, United Kingdom. · Breast International Group, Brussels, Belgium. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, Maryland. · Department of Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Rapid City Regional Hospital, Rapid City, South Dakota. · Breast Center, University of Ulm, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Jacksonville, Florida. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Harvard TH Chan School of Public Health, Boston, Massachusetts. · Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Pubmed 30335191
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kingussie, UK. · Breast Cancer Therapeutics, National Cancer Institute, Bethesda, MD. · Novartis Pharma AG, Basel, Switzerland. · Breast International Group, Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Policlinico San Martino-IRCCS per l'Oncologia, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada. · Johns Hopkins School of Medicine, Baltimore, MD. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · Department of Medicine, PUCRS, School of Medicine, Porto Alegre, Brazil. · Instituto Nacional de Câncer, Rio de Janeiro, Brazil. · Memorial Sloan Kettering Cancer Center, New York, NY. · Mayo Clinic, Jacksonville, FL. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA. · Pubmed 29878225
  • Instituto Nacional de Câncer and Clínica São Vicente, Rio de Janeiro, Brazil. Electronic address: · Frontier Science, Kincraig, United Kingdom. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Milan and European Institute of Oncology, Scientific Institute for Research, Hospitalization, and Healthcare, Milan, Italy. · The Breast International Group, Brussels, Belgium; Bristol-Myers Squibb, Princeton, NJ. · Roche Pharma, Bern, Switzerland. · The Breast International Group, Brussels, Belgium. · Breast European Adjuvant Study Team Data Center, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Roche Products, Welwyn Garden City, United Kingdom. · Genentech, South San Francisco, CA. · Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Harvard T.H. Chan School of Public Health, Boston, MA; Frontier Science and Technology Research Foundation, Boston, MA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Center Frankfurt Höchst, Frankfurt, Germany. · Pubmed 31924513
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Istitut Jules Bordet, Universitè Libre de Bruxelles, Belgium. · Breast International Group (BIG)-aisbl, Bruxelles, Belgium. · Yale Cancer Center, Yale School of Medicine, New Haven, USA. · Brustzentrum der Universität München (LMU), Munchen, Germany. · Oncology Clinical Development, Oncology Business Unit, Novartis Pharma AG, Basel, Switzerland. · Vall D'Hebron Institute of Oncology, Barcelona, Spain. · University of Ulm, Ulm, Germany. · IRCCS Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy. · Antonio Perrino Hospital, Brindisi, Italy. · IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri' Milano, Italy. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: · Pubmed 31284184
  • Frontier Science (Scotland), Kincraig, Kingussie. · Novartis Pharmaceuticals UK Limited, Frimley, UK. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA. · Medical Support Team of the Academic Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels. · Breast International Group (BIG), Brussels, Belgium. · Alliance for Clinical Trials in Oncology (formerly North Central Cancer Treatment Group), Mayo Clinic, Jacksonville. · AstraZeneca, Gaithersburg, USA. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Alliance Statistics and Data Center, Mayo Clinic, Scottsdale. · Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, USA. Electronic address: · Pubmed 31240310
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Fertility Clinic, CUB-Hôpital Erasme and Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 30847021
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Clinical Epidemiology Unit, Ospedale Policlinico San Martino, Genova, Italy. · Department of Medical Oncology, U.O. Oncologia Medica 2, Ospedale Policlinico San Martino, University of Genova, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Pubmed 30465156
2018
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 29636992
  • School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. · National Institute for Health Technology Assessment (IATS), Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · LACOG (Latin American Cooperative Oncology Group), Porto Alegre, Brazil. · Hospital do Câncer Mãe de Deus, Porto Alegre, Brazil. · University of Missouri, Columbia, SC, United States. · Department of Public Health Sciences, The University of Chicago, Chicago, IL, United States. · Harvard Medical School, Boston, MA, United States. · Massachusetts General Hospital, Boston, MA, United States. · Dana-Farber Cancer Institute, Boston, MA, United States. · Department of Radiology and Oncology, The State of Sao Paulo Cancer Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil. · CLION, CAM Group, Salvador, Brazil. · Department of Medical Oncology, Hospital São Lucas da PUCRS, Porto Alegre, Brazil. · Institut Jules Bordet and Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Innovation in Global Health, Department of Medicine, The University of Chicago, Chicago, IL, United States. · Pubmed 29872641
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Leducuba, Universidade de Lisboa, Lisbon, Portugal. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: · Pubmed 29108713
  • Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: · Department of Medical Oncology, Fouad Khoury and Makassed General Hospital, Beirut, Lebanon. · Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Department of Surgery, Waikato Hospital, University of Auckland School of Health Sciences, Hamilton, New Zealand. · Swedish Breast Cancer Group and Department of Oncology, Linköping University, Linköping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain (on behalf the Grupo Español de Investigación en Cáncer de Mama). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, and Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Department of Radiation Oncology, Sir Charles Gairdner Hospital, University of Western Australia, Genesis Cancer Care, Edith Cowan University, and Breast Cancer Trials Australia & New Zealand, Perth, Australia. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · International Breast Cancer Study Group, Bern, Switzerland; Peter MacCallum Cancer Centre, Melbourne, Australia; St. Vincents's Hospital, University of Melbourne, Australia; Breast Cancer Trials Australia & New Zealand, University of Newcastle, Newcastle, Australia. · Pubmed 29534902
  • Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Frontier Science Foundation-Hellas, Zografou, and National and Kapodistrian University of Athens, Athens, Greece. · Department of Surgery, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria. · The Royal Marsden Hospital, London, United Kingdom. · Oncology Biomarker Development, Genentech, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pathology Department, University Hospital "Fundacion Jimenez Diaz," Madrid, Spain. · University of Milan, European Institute of Oncology, Milan, Italy. · Department of Surgery, Kyoto University, Kyoto, Japan. · Breast Center, University of Munich (LMU), Munich, Germany. · Sunnybrook Odette Cancer Centre, Toronto Sunnybrook Regional Cancer Centre, Toronto, Canada. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Westmead Hospital, University of Sydney, Sydney, Australia. · Breast International Group (BIG), Brussels, Belgium. · Avera Cancer Institute, Sioux Falls, South Dakota. · Pubmed 29530933
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Unité de Gestion de l'Information, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Medical Oncology Clinic, Charleroi Universitary Hospital, Université Libre de Bruxelles (U.L.B.), Charleroi, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 30425844
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium. · Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, centre affilié de l'Université de Sherbrooke, Quebec, Canada. · Department I of Internal Medicine, Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino, Department of Internal Medicine and Medical Specialties (DIMI), University of Genova, Genova, Italy. · Pubmed 29942664
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Computational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Center, East Melbourne, Victoria, Australia. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Obstetrics and Gynecology, University of Munich, Munich, Germany. · Novartis AG, Basel, Switzerland. · Department of Oncology, Istituto Nazionale Tumori, Milan, Italy. · Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany. · Breast Medical Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 29902299
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, Oncologia Medica 2, School of Medicine, University of Genova, Genova, Italy. · Unit of Clinical Epidemiology, School of Medicine, University of Genova, Genova, Italy. · Health Direction, School of Medicine, University of Genova, Genova, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino IRCCS per l'Oncologia, School of Medicine, University of Genova, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29873695
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Département d'hémato-oncologie, CISSS Montérégie-centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, Qc, Canada. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 29474991
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Breast Surgery, University Hospital Herlev, Copenhagen, Denmark. · Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Vall D'Hebron University Hospital, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · Macerata Hospital, Macerata, Italy. · Danish Breast Cancer Group, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group Statistical Centre, Dana-Farber Cancer Institute, Boston, MA. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · European Institute of Oncology, Milan, Italy. · Pubmed 29087485
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Fertility Clinic, CUB-Hôpital Erasme and Research Laboratory on Human Reproduction, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universiade de Lisboa, Lisbon, Portugal. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · Medical Genetics Department, CUB-Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29045555
2017
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. · Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Medical Support Team of the Academic Promoting Team (APT), Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Pubmed 28762384
  • Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. · Department of Medical Oncology and IRON/U1245, Centre Henri Becquerel, Rouen, France. · Breast Cancer Translational Research Laboratory. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 28744140
  • a Clinique d'Oncologie Médicale, Institut Jules Bordet , Université Libre de Bruxelles (U.LB) , Brussels , Belgium. · b Département d'hémato-oncologie , CISSS Montérégie centre/Hôpital Charles Lemoyne, centre affilié de l'Université de Sherbrooke , Greenfield Park , Qc , Canada. · c Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University of Cologne , Cologne , Germany. · d Breast Cancer Translational Research Laboratory, Institut Jules Bordet , Université Libre de Bruxelles (U.L.B) , Brussels , Belgium. · Pubmed 28697311
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel · Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom · Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy · Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles · Debora Fumagalli, Breast International Group, Brussels, Belgium · Severine Sarp, Novartis Pharma AG, Basel, Switzerland · Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD · Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH · Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA · Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL · Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark · Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands · Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia · Sergio D. Simon, Hospital Israelita Albert Einstein · Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil · Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile · Masakazu Toi, Kyoto University, Kyoto, Japan · Maccon Keane, University Hospital Galway, Galway · and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland. · Pubmed 28375706
  • University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. Electronic address: · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · Frontier Science Scotland Ltd, Kincraig, Kingussie, UK. · European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital, and The Institute of Cancer Research, London, UK. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Avera Cancer Institute Center for Precision Oncology, Sioux Falls, SD, USA. · Deakin University, Waurn Ponds, VIC, Australia. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Pubmed 28215665
  • Dimitrios Zardavas, Breast International Group · Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Thomas M. Suter, Bern University Hospital, Bern · Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland · and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. · Pubmed 28199174
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Liverpool and Merseyside Academic Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, UK. · Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Oncology, West Middlesex University Hospital, London, UK. · Department of Clinical Oncology, The Royal United Hospital, Combe Park, Bath, UK. · Ealing Hospital NHS Trust, Middlesex, UK. · Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK. · University of Manchester, Institute of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Pubmed 26334099
2015
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Hôpital Ambroise Pare, Mons, Belgium. · Neuropsychologue CHIREC, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cardiology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, Liege, Belgium. · Department of Oncology, CHU Tivoli - GOHH, La Louviere, Belgium. · Clinique Ste-Elisabeth, Namur, Belgium. · Department of Oncology, Hôpital de Jolimont, Haine St Paul, Belgium. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland. · Pubmed 26321502
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25899784
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles · Dimitrios Zardavas, Breast International Group, Brussels, Belgium · Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia · and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 24794210
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium ; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Brussels, Belgium. · Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Pubmed 24415979
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
2013
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Boulevard de Waterloo, 121 (7th floor), 1000 Brussels, Belgium. · Pubmed 24074778
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Pubmed 24078620
  • Breast International Group, Brussels, Belgium; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23643661
Probable:    Miscellaneous institutions in Brussels      
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 110 total) written by Evandro de Azambuja about Breast Neoplasms:

  • Post-Mastectomy Radiation Therapy in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients: Analysis of the HERA Trial. 2020
  • Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy. 2020
  • Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials. 2020
  • Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer. 2020
  • A pooled analysis of the cardiac events in the trastuzumab adjuvant trials. 2020
  • ER+/HER2+ breast cancer: are we really de-escalating? 2019
  • Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors. 2019
  • How I treat metastatic triple-negative breast cancer. 2019
  • Targeted therapy for breast cancer in older patients. 2019
  • Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer. 2019
Show List of Full Article Records
Google Searches

Learn more about Evandro de Azambuja using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Jules Bordet Institute
Universite Libre de Bruxelles
Miscellaneous institutions in Brussels
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Jules Bordet Institute
2020
  • Faculty of Medicine, American University of Beirut, Beirut, Lebanon. · Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Division of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. · Department of Radiation Oncology, Institut Curie & Paris Sciences & Lettres, PSL University, Paris, France. · Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: · Pubmed 31654782
  • Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Vall D'Hebron Institute of Oncology, 08035 Barcelona, Spain. · Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), 1000 Brussels, Belgium. · Department of Obstetrics and Gynecology, University of Ulm, 89081 Ulm, Germany. · Novartis Pharmaceutical, 4002 Basel, Switzerland. · SOLTI-Breast Cancer Research Group, 08035 Barcelona, Spain. · Breast International Group (BIG)-aisbl, 1000 Bruxelles, Belgium. · Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, 13125 Berlin, Germany. · Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511, USA. · Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, M4N 3M5 ON, Canada. · Groupe d'étude des facteurs pronostiques immunohistochimiques dans le cancer du sein, 75013 Unicancer, France. · Department of Pathology, The UT M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, 20100 Milan, Italy. · Pubmed 32085669
  • Clinical Trials Support Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium. · AC Camargo Cancer Center, São Paulo, Brazil. · Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy. · Department of Haematology, Oncology, Hemostasiology and Stem Cell Transplant (Medizinische Klinik IV), Uniklinik RWTH Aachen, Aachen, Germany. · CHU Saint-Pierre, Bruxelles, Belgium. · Clinical Trials Support Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium · Pubmed 32079624
  • Academic Promoting Team, Research Department, Institut Jules Bordet, Brussels, Belgium; AC Camargo Cancer Center, Sao Paulo, Brazil. · Statistical Department, Institut Jules Bordet, Brussels, Belgium. · Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Research Department, Institut Jules Bordet, Brussels, Belgium. · Academic Promoting Team, Research Department, Institut Jules Bordet, Brussels, Belgium. Electronic address: · Pubmed 31923729
  • Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. · AC Camargo Cancer Center, Sao Paulo, Brazil. · Frontier Science (Scotland), Kincraig, UK. · NRG Oncology, and The University of Pittsburgh Medical Center, Pittsburgh, PA, USA. · NRG Oncology, and the University of Pittsburgh, Pittsburgh, PA, USA. · IRCCS Ospedale Policlinico San Martino and University of Genova, GENOVA, Italy. · Mayo Clinic, Jacksonville, FL, USA. · Breast International Group (BIG), Brussels, Belgium. · Institut Regional du Cancer Montpellier Val d'Aurelle, Montpellier, France. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Bern, Bern, Switzerland. · Pubmed 31605311
2019
  • Department of Medical Oncology, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 30993330
  • Academic Trials Promoting Team. · Academic Trials Promoting Team; Medical Oncology Department, Institut Jules Bordet. Electronic address: · Pubmed 31928692
  • Department of Medical Oncology, Institut Jules Bordet, Bruxelles, Belgium. · Department of Medical Oncology, UOC Clinica di Oncologia Medica, Ospedale Policlinico San Martino, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Pubmed 31231572
  • Medical Support Team, Institut Jules Bordet, Brussels, Belgium. Electronic address: · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Medical Support Team, Institut Jules Bordet, Brussels, Belgium. · Pharmacy Department, Institut Jules Bordet, Brussels, Belgium. · Pubmed 31171494
  • Division of Early Drug Development, University of Milan, IRCCS European Institute of Oncology, Milan, Italy · Department of Medical Oncology, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium. · Cardio-Oncology Center of Excellence, Washington University, St. Louis, Missouri, USA. · Department of Anaesthesiology and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. · Cardioncology Unit, European Institute of Oncology, Milan, Italy. · Cardiology Division, European Institute of Oncology, Milan, Italy. · Pubmed 31064888
  • Institut Jules Bordet - Université Libre de Bruxelles (ULB); Medical Oncology Department, Academic Promoting Team at Boulevard de Waterloo, 121, 1000, Brussels, Belgium. · Pubmed 30938542
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Bruxelles, Belgium. · Pubmed 30833989
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Frontier Science, Kingussie, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · IEO, European Institute of Oncology IRCCS, University of Milan, Milan, Italy. · Mayo Clinic, Phoenix, AZ, USA. · Breast International Group, Brussels, Belgium. · National Cancer Institute, Bethesda, MD, USA. · Novartis Pharma AG, Basel, Switzerland. · Mayo Clinic, Jacksonville, FL, USA. · Sana Klinikum Offenbach, Offenbach, Germany. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Institut Gustave Roussy, Villejuif, France. · Champalimaud Clinical Center, Champalimaud Foundation and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain. · Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 31134488
  • Medical Oncology Department, Oncologisch Centrum, UZ Brussel, Brussels, Belgium. · Medical Oncology Department, AZ Sint-Lucas, Ghent, Belgium. · Medical Oncology Department, Imelda ziekenhuis, Bonheiden, Belgium. · Medical Oncology Department, CHU UCL Namur, Namur, Belgium. · Medical Oncology Department, Cliniques Sud-Luxembourg, Virton, Belgium. · Medical Oncology Department, Chwapi, Tournai, Belgium. · Medical Oncology Department, Oncologisch Centrum, UZ Brussel, Brussels, Belgium. · Medical Oncology Department, Institut Jules Bordet, L'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of General Medical Oncology and Department of Oncology, University Hospitals Leuven, Louvain, Belgium. · Pubmed 31069589
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Frontier Science, Kingussie, U.K. · Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Klinik für Gynäkologie und Geburtshilfe, Interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Berlin, Germany. · Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, U.K. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Western General Hospital, University of Edinburgh Cancer Research Centre, Edinburgh, U.K. · Deakin University, Waurn Ponds, VIC, Australia. · Breast International Group (BIG), Brussels, Belgium. · F. Hoffmann-La Roche, Basel, Switzerland. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Harvard Medical School, Boston, MA, U.S.A. · Academic Department of Biochemistry, Royal Marsden Hospital, London, U.K. · Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, U.S.A. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 30711959
  • 1 Kantonsspital St Gallen, St Gallen, Switzerland. · 2 Dana-Farber Cancer Institute, Boston, MA. · 3 European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy. · 4 Rigshospitalet, Copenhagen, Denmark. · 5 Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium. · 6 KU Leuven, Leuven, Belgium. · 7 National Institute of Oncology, Budapest, Hungary. · 8 Lillebaelt Hospital, Vejle, Denmark. · 9 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France. · 10 Université de Bordeaux, Bordeaux, France. · 11 Auckland City Hospital, Auckland, New Zealand. · 12 CRO National Cancer Institute, Aviano, Italy. · 13 Ospedale Papa Giovanni XXIII, Bergamo, Italy. · 14 Ospedale Policlinico San Martino, Genoa, Italy. · 15 Centre de Cancérolgie Henri Becquerel, Rouen, France. · 16 ASST Spedali Civili di Brescia, Brescia, Italy. · 17 Ospedale Infermi di Rimini, AUSL della Romagna, Ravenna, Italy. · 18 Universitätsspital, Basel, Switzerland. · 19 Kantonsspital, Aarau, Switzerland. · 20 University Hospital Vaud University Hospital Center, Lausanne, Switzerland. · 21 Medical University of Gdansk, Gdansk, Poland. · 22 Hospital of Prato-AUSL Toscana Centro, Prato, Italy. · 23 Harvard Medical School, Boston, MA. · 24 Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA. · 25 University of Sydney, Sydney, NSW, Australia. · 26 International Breast Cancer Study Group, Bern, Switzerland. · Pubmed 30475668
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, Université de Sherbrooke, Quebec, Canada. · Frontier Science, Kingussie, United Kingdom. · Breast International Group, Brussels, Belgium. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, Maryland. · Department of Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Rapid City Regional Hospital, Rapid City, South Dakota. · Breast Center, University of Ulm, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Jacksonville, Florida. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Harvard TH Chan School of Public Health, Boston, Massachusetts. · Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Pubmed 30335191
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kingussie, UK. · Breast Cancer Therapeutics, National Cancer Institute, Bethesda, MD. · Novartis Pharma AG, Basel, Switzerland. · Breast International Group, Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Policlinico San Martino-IRCCS per l'Oncologia, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada. · Johns Hopkins School of Medicine, Baltimore, MD. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · Department of Medicine, PUCRS, School of Medicine, Porto Alegre, Brazil. · Instituto Nacional de Câncer, Rio de Janeiro, Brazil. · Memorial Sloan Kettering Cancer Center, New York, NY. · Mayo Clinic, Jacksonville, FL. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA. · Pubmed 29878225
  • Instituto Nacional de Câncer and Clínica São Vicente, Rio de Janeiro, Brazil. Electronic address: · Frontier Science, Kincraig, United Kingdom. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Milan and European Institute of Oncology, Scientific Institute for Research, Hospitalization, and Healthcare, Milan, Italy. · The Breast International Group, Brussels, Belgium; Bristol-Myers Squibb, Princeton, NJ. · Roche Pharma, Bern, Switzerland. · The Breast International Group, Brussels, Belgium. · Breast European Adjuvant Study Team Data Center, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Roche Products, Welwyn Garden City, United Kingdom. · Genentech, South San Francisco, CA. · Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Harvard T.H. Chan School of Public Health, Boston, MA; Frontier Science and Technology Research Foundation, Boston, MA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Center Frankfurt Höchst, Frankfurt, Germany. · Pubmed 31924513
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy. · Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy. · Medical Oncology, Istituto Nazionale Tumori-IRCCS Fondazione Pascale, Naples, Italy. · La Sapienza University, Rome, Italy. · Department of Medical Oncology 1, Istituto Nazionale Tumori Regina Elena, Rome, Italy. · Department of Medical Oncology, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy. · Breast Unit, Azienda Ospedaliera Universitaria Città della Salute e delle Scienze, Torino, Italy. · Medical Oncology, Martini Hospital, ASL Città' di Torino, Italy. · Department of Medical Oncology, Hospital Businco, Cagliari, Italy. · Breast Unit, Medical Oncology, Azienda Ospedaliera S. Croce e Carle, Ospedale di Insegnamento, Cuneo, Italy. · Unit of Medical Oncology and Cancer Prevention, IRCCS Centro di Riferimento Oncologico Aviano-National Cancer Institute, Aviano (Udine), Italy. · Medical Oncology, Department of Medicine, University of Udine, Udine, Italy. · Day Hospital Oncologico Multidisciplinare, Istituto di Candiolo, FPO-IRCCS, Candiolo, Torino, Italy. · Pubmed 31724170
  • University of Ulm, Breast Center, Ulm, Germany. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Executive Vice President, Research & Development Oncology, AstraZeneca, United Kingdom. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Head of Breast Cancer Center, Department of Gynecology, Gynecologic Oncology and Obstetrics, HELIOS Klinikum Berlin, Buch, Germany. · Breast International Group, Brussels, Belgium. · Novartis Pharma AG, Oncology Development Unit, Basel, Switzerland. · Istenhegyi Gendiagnosztika Private Health Center, Oncology Clinic, Budapest, Hungary. · Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · KU Leuven - University of Leuven, Department of General Medical Oncology, University Hospitals Leuven, B-3000, Leuven, Belgium. · CRLCC Jean Godinot, Reims, France. · Marien-Hospital Witten, Witten, Germany. · Kidwai Memorial Institute of Oncology, Bangalore, India. · Hospital Doce de Octubre, Madrid, Spain. · Hospital Torrevieja-Salud, Torrevieja, Spain. · Krivoy Rog City Oncology Centre, Krivoy Rog, Ukraine. · Royal Bournemouth Hospital & Bournemouth University, Bournemouth, United Kingdom. · SOLTI - Breast Cancer Research Group, Barcelona, Spain. · Sana Klinikum Offenbach, Offenbach, Germany. · Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, USA. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Barcelona, Spain. · Pubmed 31377477
  • AC Camargo Cancer Center, Department of Medical Oncology, São Paulo, Brazil. · Institut Jules Bordet, Department of Research, Brussels, Belgium. · Pubmed 31341271
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Istitut Jules Bordet, Universitè Libre de Bruxelles, Belgium. · Breast International Group (BIG)-aisbl, Bruxelles, Belgium. · Yale Cancer Center, Yale School of Medicine, New Haven, USA. · Brustzentrum der Universität München (LMU), Munchen, Germany. · Oncology Clinical Development, Oncology Business Unit, Novartis Pharma AG, Basel, Switzerland. · Vall D'Hebron Institute of Oncology, Barcelona, Spain. · University of Ulm, Ulm, Germany. · IRCCS Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy. · Antonio Perrino Hospital, Brindisi, Italy. · IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri' Milano, Italy. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: · Pubmed 31284184
  • Frontier Science (Scotland), Kincraig, Kingussie. · Novartis Pharmaceuticals UK Limited, Frimley, UK. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA. · Medical Support Team of the Academic Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels. · Breast International Group (BIG), Brussels, Belgium. · Alliance for Clinical Trials in Oncology (formerly North Central Cancer Treatment Group), Mayo Clinic, Jacksonville. · AstraZeneca, Gaithersburg, USA. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Alliance Statistics and Data Center, Mayo Clinic, Scottsdale. · Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, USA. Electronic address: · Pubmed 31240310
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Fertility Clinic, CUB-Hôpital Erasme and Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 30847021
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Clinical Epidemiology Unit, Ospedale Policlinico San Martino, Genova, Italy. · Department of Medical Oncology, U.O. Oncologia Medica 2, Ospedale Policlinico San Martino, University of Genova, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Pubmed 30465156
2018
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 29636992
  • Department of Medical Oncology, Institut Jules Bordet, L'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino IRCCS per l'Oncologia, Genova, Italy. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, L'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29387483
  • Institut Jules Bordet, Blvd the Waterloo, Brussels, Belgium. · Institut Jules Bordet, Blvd the Waterloo, Brussels, Belgium. · Pubmed 29307195
  • Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. · Comprehensive Cancer Centre, Medical University Vienna - General Hospital, Vienna, Austria. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Gynaecology and Obstetrics, Agaplesion Markus Hospital, Frankfurt am Main, Germany. · Division of Experimental Therapeutics, European Institute of Oncology, Milano, Italy. · German Breast Group, Neu-Isenburg, Germany. · Breast Center St. Gallen, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Medicine Department, Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 30167331
  • School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. · National Institute for Health Technology Assessment (IATS), Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · LACOG (Latin American Cooperative Oncology Group), Porto Alegre, Brazil. · Hospital do Câncer Mãe de Deus, Porto Alegre, Brazil. · University of Missouri, Columbia, SC, United States. · Department of Public Health Sciences, The University of Chicago, Chicago, IL, United States. · Harvard Medical School, Boston, MA, United States. · Massachusetts General Hospital, Boston, MA, United States. · Dana-Farber Cancer Institute, Boston, MA, United States. · Department of Radiology and Oncology, The State of Sao Paulo Cancer Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil. · CLION, CAM Group, Salvador, Brazil. · Department of Medical Oncology, Hospital São Lucas da PUCRS, Porto Alegre, Brazil. · Institut Jules Bordet and Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Innovation in Global Health, Department of Medicine, The University of Chicago, Chicago, IL, United States. · Pubmed 29872641
  • a Medical Department , Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B.) , Brussels , Belgium. · b Department of Medical Oncology , Oncologia Medica 2, Ospedale Policlinico San Martino IRCCS per l'Oncologia , Genova , Italy. · c Clinical Oncology Department , Hospital Santa Rita, Complexo Hospitalar Irmandade Santa Casa de Misericórdia de Porto Alegre; Rua Sarmento Leite , Porto Alegre , RS , Brazil. · Pubmed 29781317
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Leducuba, Universidade de Lisboa, Lisbon, Portugal. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: · Pubmed 29108713
  • Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Frontier Science Foundation-Hellas, Zografou, and National and Kapodistrian University of Athens, Athens, Greece. · Department of Surgery, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria. · The Royal Marsden Hospital, London, United Kingdom. · Oncology Biomarker Development, Genentech, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pathology Department, University Hospital "Fundacion Jimenez Diaz," Madrid, Spain. · University of Milan, European Institute of Oncology, Milan, Italy. · Department of Surgery, Kyoto University, Kyoto, Japan. · Breast Center, University of Munich (LMU), Munich, Germany. · Sunnybrook Odette Cancer Centre, Toronto Sunnybrook Regional Cancer Centre, Toronto, Canada. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Westmead Hospital, University of Sydney, Sydney, Australia. · Breast International Group (BIG), Brussels, Belgium. · Avera Cancer Institute, Sioux Falls, South Dakota. · Pubmed 29530933
  • Breast Cancer Research Laboratory, Department of Medicine, Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Blvd de Waterloo 121, Brussels, Belgium. · Frontier Science (Scotland) Ltd., Grampian View, Kingussie, PH21 1NA, UK. · MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Breast International Group, Boulevard de Waterloo 76, 1000, Brussels, Belgium. · Istituto Nazionale del Tumori, Via Giacomo Venezian, 1, 20133, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast Center, University of Ulm, Helmholtzstraße 16, 89081, Ulm, Germany. · Oncology Clinical Development, Oncology Business Unit, Novartis Pharma AG, Klybeckstrasse, 4057, Basel, Switzerland. · Institute for Oncology and Radiology of Serbia, National Cancer Research Center University of Belgrade, Pasterova 14, Belgrade, Serbia. · Brustzentrum, Frauenklinik der Universität München, Klinikum der Universität München, Maistraße 11, Munich, Germany. · Allgemeines Krankenhaus Celle, Siemenspl. 4, 29223, Celle, Germany. · Samsung Medical Center, 81 Irwon-ro, Irwon-dong, Gangnam-gu, Seoul, South Korea. · Hospital Virgen del Rocio, Avenida Manuel Siurot, S/N, 41013, Seville, Spain. · Changhua Christian Hospital, No. 176, Zhonghua Road, Changhua City, Changhua County, Taiwan, 500. · Mayo Clinic, 200 1st St SW, Rochester, MN, USA. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Freiburgstrasse 8, 3010, Bern, Switzerland. · Breast Cancer Research Laboratory, Department of Medicine, Institut Jules Bordet and L'Université Libre de Bruxelles (U.L.B), Blvd de Waterloo 121, Brussels, Belgium. · Pubmed 29280043
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Unité de Gestion de l'Information, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Medical Oncology Clinic, Charleroi Universitary Hospital, Université Libre de Bruxelles (U.L.B.), Charleroi, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 30425844
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium. · Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, centre affilié de l'Université de Sherbrooke, Quebec, Canada. · Department I of Internal Medicine, Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino, Department of Internal Medicine and Medical Specialties (DIMI), University of Genova, Genova, Italy. · Pubmed 29942664
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Computational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Center, East Melbourne, Victoria, Australia. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Obstetrics and Gynecology, University of Munich, Munich, Germany. · Novartis AG, Basel, Switzerland. · Department of Oncology, Istituto Nazionale Tumori, Milan, Italy. · Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany. · Breast Medical Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 29902299
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, Oncologia Medica 2, School of Medicine, University of Genova, Genova, Italy. · Unit of Clinical Epidemiology, School of Medicine, University of Genova, Genova, Italy. · Health Direction, School of Medicine, University of Genova, Genova, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino IRCCS per l'Oncologia, School of Medicine, University of Genova, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29873695
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Département d'hémato-oncologie, CISSS Montérégie-centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, Qc, Canada. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 29474991
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Breast Surgery, University Hospital Herlev, Copenhagen, Denmark. · Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Vall D'Hebron University Hospital, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · Macerata Hospital, Macerata, Italy. · Danish Breast Cancer Group, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group Statistical Centre, Dana-Farber Cancer Institute, Boston, MA. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · European Institute of Oncology, Milan, Italy. · Pubmed 29087485
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Fertility Clinic, CUB-Hôpital Erasme and Research Laboratory on Human Reproduction, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universiade de Lisboa, Lisbon, Portugal. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · Medical Genetics Department, CUB-Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29045555
2017
  • Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium. · Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, Universitat zu Koln, Koln, Nordrhein-Westfalen, Germany. · Département d'Hémato-Oncologie, Hopital Charles-Lemoyne, Greenfield Par, Quebec, Canada. · Pubmed 28761736
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. · Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Medical Support Team of the Academic Promoting Team (APT), Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Pubmed 28762384
  • Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. · Department of Medical Oncology and IRON/U1245, Centre Henri Becquerel, Rouen, France. · Breast Cancer Translational Research Laboratory. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 28744140
  • a Clinique d'Oncologie Médicale, Institut Jules Bordet , Université Libre de Bruxelles (U.LB) , Brussels , Belgium. · b Département d'hémato-oncologie , CISSS Montérégie centre/Hôpital Charles Lemoyne, centre affilié de l'Université de Sherbrooke , Greenfield Park , Qc , Canada. · c Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University of Cologne , Cologne , Germany. · d Breast Cancer Translational Research Laboratory, Institut Jules Bordet , Université Libre de Bruxelles (U.L.B) , Brussels , Belgium. · Pubmed 28697311
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genoa, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Molecular Immunology Unit, Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 28185173
  • a BrEAST Data Centre, Institut Jules Bordet , l'Université Libre de Bruxelles (U.L.B.) , Brussels , Belgium. · b Breast Cancer Translational Research Laboratory , Institut Jules Bordet , Brussels , Belgium. · c Molecular Immunology Unit , Institut Jules Bordet , Brussels , Belgium. · Pubmed 27883296
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Dimitrios Zardavas, Breast International Group · Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Thomas M. Suter, Bern University Hospital, Bern · Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland · and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. · Pubmed 28199174
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • Department of Medicine I , Medical University of Vienna , Vienna , Austria. · Department of Medical Oncology , Institut Jules Bordet , Brussels , Belgium. · Pubmed 27900209
  • BrEAST Data Center, Institut Jules Bordet , Brussels , Belgium. · BrEAST Data Center, Institut Jules Bordet, Brussels, Belgium; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Genova, Italy. · Pubmed 27843627
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Data Centre, Institut Jules Bordet, and l'Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Largo Rosanna Benzi 10, 16132 Genova, Italy. · Department of Medical and Biological Sciences, University of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Oncology, University Hospital of Udine, Piazzale Santa Maria della Misericordia 15, 33010 Udine, Italy. · Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research, KU Leuven-University of Leuven, B-3000 Leuven, Belgium. · Department of Pathology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of General Medical Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Department of Gynecology and Obstetrics, KU Leuven-University of Leuven, University Hospitals Leuven, B-3000 Leuven, Belgium. · Pubmed 27802449
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Medical Oncology and Breast Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. · Pubmed 26654400
  • Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Liverpool and Merseyside Academic Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, UK. · Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Oncology, West Middlesex University Hospital, London, UK. · Department of Clinical Oncology, The Royal United Hospital, Combe Park, Bath, UK. · Ealing Hospital NHS Trust, Middlesex, UK. · Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK. · University of Manchester, Institute of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Pubmed 26334099
2015
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Hôpital Ambroise Pare, Mons, Belgium. · Neuropsychologue CHIREC, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cardiology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, Liege, Belgium. · Department of Oncology, CHU Tivoli - GOHH, La Louviere, Belgium. · Clinique Ste-Elisabeth, Namur, Belgium. · Department of Oncology, Hôpital de Jolimont, Haine St Paul, Belgium. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland. · Pubmed 26321502
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands · Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology · Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain · Holger Eidtmann, University Hospital Kiel, Kiel · Nadia Harbeck, University of Munich, Munich, Germany · Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom · Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles · Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium · Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Catherine Ellis, GlaxoSmithKline, Collegeville, PA · and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • Ciara C. O'Sullivan and Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Ian Bradbury, Christine Campbell, and Eileen Holmes, Frontier Science, Inverness-shire, Scotland · Marc Spielmann and Suzette Delaloge, Institut de Cancérologie Gustave Roussy, Villejuif, France · Edith A. Perez, Mayo Clinic, Jacksonville, FL · Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland · Joseph P. Costantino and Priya Rastogi, University of Pittsburgh, Pittsburgh, PA · Dimitrios Zardavas, Breast International Group · Karla V. Ballman, Mayo Clinic, Rochester, MN · Evandro de Azambuja and Martine Piccart-Gebhart, Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium · and Richard D. Gelber, Harvard Medical School, Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute, and Frontier Science and Technology Research Foundation, Boston, MA. · Pubmed 26101239
  • Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Frontier Science (Scotland) Ltd., Inverness-shire, Scotland. · Clinical Research, Monogram Biosciences, Inc., South San Francisco, California. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Breast Center, Department of Obstetrics and Gynecology, and CCC LMU, University of Munich, Munich, Germany. · Genetics and Genomics Program, Yale School of Medicine, New Haven, Connecticut. · Oncology R&D, GlaxoSmithKline, Collegeville, Pennsylvania. · Department of Gynecology and Midwifery, University Hospital Kiel, Kiel, Germany. · Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Jules Bordet Institute, Brussels, Belgium. · Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, New York. Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 25467182
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25899784
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles · Dimitrios Zardavas, Breast International Group, Brussels, Belgium · Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia · and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 24794210
  • Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. Electronic address: · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Istituto Nazionale del Tumori, Milan, Italy; SOLTI Breast Cancer Research Group, Spain. · GlaxoSmithKline, Collegeville, PA, USA. · Clinic for Gynaecology, Gynaecologic Oncology and Obstetrics and Breast Cancer Centre, HELIOS Klinikum Berlin, Buch, Germany. · Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, NSW, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · PUC-RS School of Medicine, Porto Alegre, Brazil. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet and Breast European Adjuvant Study Team, Brussels, Belgium. · Asian Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · Kliniken Essen-Mitte, Essen, Germany. · National Taiwan University Hospital, Taipei, Taiwan. · Clinique St-Elisabeth, Namur, Belgium. · Mackay Memorial Hospital, Taipei, Taiwan. · Kashirskoye Shosse, Moscow, Russia. · Cancer Institute "Prof Dr Ion Chiricuta", Cluj-Napoca, Romania. · Department of Medical Oncology, University of Pretoria, Pretoria, South Africa. · Odessa Oncology Centre, Odessa, Ukraine. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Kiel, Kiel, Germany. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25130998
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. Electronic address: · Department of Medical Oncology and Breast Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, 1000 Brussels, Belgium. · Department of Obstetrics and Gynaecology, CHU Saint-Pierre, Rue Haute 322, 1000 Brussels, Belgium. · Pubmed 25156453
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
  • Department of Medical Oncology, Institut Jules Bordet, Brussels. · Data Centre, Institut Jules Bordet, Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Brussels · Pubmed 24562450
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium ; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Brussels, Belgium. · Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Pubmed 24415979
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
2013
  • Medical Oncology Department, Institut Jules Bordet, Br.E.A.S.T. Data Centre Brussels, Blvd de Waterloo, 121 (7th Floor), 1000 Brussels, Belgium. · Pubmed 24138446
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Boulevard de Waterloo, 121 (7th floor), 1000 Brussels, Belgium. · Pubmed 24074778
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Breast Cancer Translational Research Laboratory (BCTL) J.C. Heuson, Institut Jules Bordet, Blvd de Waterloo, 125, 1000 Brussels, Belgium. · Pubmed 23341518
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Pubmed 24078620
  • Breast International Group, Brussels, Belgium; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23643661
Universite Libre de Bruxelles
2020
  • Clinical Trials Support Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium. · AC Camargo Cancer Center, São Paulo, Brazil. · Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy. · Department of Haematology, Oncology, Hemostasiology and Stem Cell Transplant (Medizinische Klinik IV), Uniklinik RWTH Aachen, Aachen, Germany. · CHU Saint-Pierre, Bruxelles, Belgium. · Clinical Trials Support Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium · Pubmed 32079624
  • Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Boulevard de Waterloo, 121 (7th Floor), 1000, Brussels, Belgium. · AC Camargo Cancer Center, Sao Paulo, Brazil. · Frontier Science (Scotland), Kincraig, UK. · NRG Oncology, and The University of Pittsburgh Medical Center, Pittsburgh, PA, USA. · NRG Oncology, and the University of Pittsburgh, Pittsburgh, PA, USA. · IRCCS Ospedale Policlinico San Martino and University of Genova, GENOVA, Italy. · Mayo Clinic, Jacksonville, FL, USA. · Breast International Group (BIG), Brussels, Belgium. · Institut Regional du Cancer Montpellier Val d'Aurelle, Montpellier, France. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, and Frontier Science and Technology Research Foundation, Boston, MA, USA. · University Hospital Bern, Bern, Switzerland. · Pubmed 31605311
2019
  • Institut Jules Bordet - Université Libre de Bruxelles (ULB); Medical Oncology Department, Academic Promoting Team at Boulevard de Waterloo, 121, 1000, Brussels, Belgium. · Pubmed 30938542
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Bruxelles, Belgium. · Pubmed 30833989
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Frontier Science, Kingussie, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · IEO, European Institute of Oncology IRCCS, University of Milan, Milan, Italy. · Mayo Clinic, Phoenix, AZ, USA. · Breast International Group, Brussels, Belgium. · National Cancer Institute, Bethesda, MD, USA. · Novartis Pharma AG, Basel, Switzerland. · Mayo Clinic, Jacksonville, FL, USA. · Sana Klinikum Offenbach, Offenbach, Germany. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Institut Gustave Roussy, Villejuif, France. · Champalimaud Clinical Center, Champalimaud Foundation and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain. · Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 31134488
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Frontier Science, Kingussie, U.K. · Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Klinik für Gynäkologie und Geburtshilfe, Interdisziplinäres Brustzentrum, HELIOS Klinikum Berlin Buch, Berlin, Germany. · Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, U.K. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Western General Hospital, University of Edinburgh Cancer Research Centre, Edinburgh, U.K. · Deakin University, Waurn Ponds, VIC, Australia. · Breast International Group (BIG), Brussels, Belgium. · F. Hoffmann-La Roche, Basel, Switzerland. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Harvard Medical School, Boston, MA, U.S.A. · Academic Department of Biochemistry, Royal Marsden Hospital, London, U.K. · Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, U.S.A. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 30711959
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, Université de Sherbrooke, Quebec, Canada. · Frontier Science, Kingussie, United Kingdom. · Breast International Group, Brussels, Belgium. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, Maryland. · Department of Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Rapid City Regional Hospital, Rapid City, South Dakota. · Breast Center, University of Ulm, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Jacksonville, Florida. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Harvard TH Chan School of Public Health, Boston, Massachusetts. · Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Pubmed 30335191
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kingussie, UK. · Breast Cancer Therapeutics, National Cancer Institute, Bethesda, MD. · Novartis Pharma AG, Basel, Switzerland. · Breast International Group, Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Policlinico San Martino-IRCCS per l'Oncologia, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada. · Johns Hopkins School of Medicine, Baltimore, MD. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · National Institute of Oncology, Budapest, Hungary. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK. · Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia. · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. · Department of Medicine, PUCRS, School of Medicine, Porto Alegre, Brazil. · Instituto Nacional de Câncer, Rio de Janeiro, Brazil. · Memorial Sloan Kettering Cancer Center, New York, NY. · Mayo Clinic, Jacksonville, FL. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA. · Pubmed 29878225
  • Instituto Nacional de Câncer and Clínica São Vicente, Rio de Janeiro, Brazil. Electronic address: · Frontier Science, Kincraig, United Kingdom. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Milan and European Institute of Oncology, Scientific Institute for Research, Hospitalization, and Healthcare, Milan, Italy. · The Breast International Group, Brussels, Belgium; Bristol-Myers Squibb, Princeton, NJ. · Roche Pharma, Bern, Switzerland. · The Breast International Group, Brussels, Belgium. · Breast European Adjuvant Study Team Data Center, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. · Roche Products, Welwyn Garden City, United Kingdom. · Genentech, South San Francisco, CA. · Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Harvard T.H. Chan School of Public Health, Boston, MA; Frontier Science and Technology Research Foundation, Boston, MA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Center Frankfurt Höchst, Frankfurt, Germany. · Pubmed 31924513
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. · Istitut Jules Bordet, Universitè Libre de Bruxelles, Belgium. · Breast International Group (BIG)-aisbl, Bruxelles, Belgium. · Yale Cancer Center, Yale School of Medicine, New Haven, USA. · Brustzentrum der Universität München (LMU), Munchen, Germany. · Oncology Clinical Development, Oncology Business Unit, Novartis Pharma AG, Basel, Switzerland. · Vall D'Hebron Institute of Oncology, Barcelona, Spain. · University of Ulm, Ulm, Germany. · IRCCS Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy. · Antonio Perrino Hospital, Brindisi, Italy. · IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri' Milano, Italy. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: · Pubmed 31284184
  • Frontier Science (Scotland), Kincraig, Kingussie. · Novartis Pharmaceuticals UK Limited, Frimley, UK. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, USA. · Medical Support Team of the Academic Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels. · Breast International Group (BIG), Brussels, Belgium. · Alliance for Clinical Trials in Oncology (formerly North Central Cancer Treatment Group), Mayo Clinic, Jacksonville. · AstraZeneca, Gaithersburg, USA. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Alliance Statistics and Data Center, Mayo Clinic, Scottsdale. · Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, USA. Electronic address: · Pubmed 31240310
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Fertility Clinic, CUB-Hôpital Erasme and Research Laboratory on Human Reproduction, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 30847021
  • Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Clinical Epidemiology Unit, Ospedale Policlinico San Martino, Genova, Italy. · Department of Medical Oncology, U.O. Oncologia Medica 2, Ospedale Policlinico San Martino, University of Genova, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Pubmed 30465156
2018
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 29636992
  • School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. · National Institute for Health Technology Assessment (IATS), Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · LACOG (Latin American Cooperative Oncology Group), Porto Alegre, Brazil. · Hospital do Câncer Mãe de Deus, Porto Alegre, Brazil. · University of Missouri, Columbia, SC, United States. · Department of Public Health Sciences, The University of Chicago, Chicago, IL, United States. · Harvard Medical School, Boston, MA, United States. · Massachusetts General Hospital, Boston, MA, United States. · Dana-Farber Cancer Institute, Boston, MA, United States. · Department of Radiology and Oncology, The State of Sao Paulo Cancer Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil. · CLION, CAM Group, Salvador, Brazil. · Department of Medical Oncology, Hospital São Lucas da PUCRS, Porto Alegre, Brazil. · Institut Jules Bordet and Université libre de Bruxelles (ULB), Brussels, Belgium. · Center for Innovation in Global Health, Department of Medicine, The University of Chicago, Chicago, IL, United States. · Pubmed 29872641
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Leducuba, Universidade de Lisboa, Lisbon, Portugal. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino-IST, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie Centre/Hôpital Charles Lemoyne, Université de Sherbrooke, Greenfield Park, QC, Canada. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. Electronic address: · Pubmed 29108713
  • Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: · Department of Medical Oncology, Fouad Khoury and Makassed General Hospital, Beirut, Lebanon. · Data Centre, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, Harvard Medical School, and Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Department of Surgery, Waikato Hospital, University of Auckland School of Health Sciences, Hamilton, New Zealand. · Swedish Breast Cancer Group and Department of Oncology, Linköping University, Linköping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Valencia, Spain (on behalf the Grupo Español de Investigación en Cáncer de Mama). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, and Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group, Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Department of Radiation Oncology, Sir Charles Gairdner Hospital, University of Western Australia, Genesis Cancer Care, Edith Cowan University, and Breast Cancer Trials Australia & New Zealand, Perth, Australia. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · International Breast Cancer Study Group, Bern, Switzerland; Peter MacCallum Cancer Centre, Melbourne, Australia; St. Vincents's Hospital, University of Melbourne, Australia; Breast Cancer Trials Australia & New Zealand, University of Newcastle, Newcastle, Australia. · Pubmed 29534902
  • Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Frontier Science Foundation-Hellas, Zografou, and National and Kapodistrian University of Athens, Athens, Greece. · Department of Surgery, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria. · The Royal Marsden Hospital, London, United Kingdom. · Oncology Biomarker Development, Genentech, Basel, Switzerland. · Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pathology Department, University Hospital "Fundacion Jimenez Diaz," Madrid, Spain. · University of Milan, European Institute of Oncology, Milan, Italy. · Department of Surgery, Kyoto University, Kyoto, Japan. · Breast Center, University of Munich (LMU), Munich, Germany. · Sunnybrook Odette Cancer Centre, Toronto Sunnybrook Regional Cancer Centre, Toronto, Canada. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, Massachusetts. · Westmead Hospital, University of Sydney, Sydney, Australia. · Breast International Group (BIG), Brussels, Belgium. · Avera Cancer Institute, Sioux Falls, South Dakota. · Pubmed 29530933
  • Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne VIC 3000, Victoria, on behalf of The Australian and New Zealand Breast Cancer Trials Group, Newcastle, NSW 2298, Australia, and International Breast Cancer Study Group, 3008 Bern, Switzerland. · 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy. · St. Vincet's University Hospital, Elm Park, on behalf of the Irish Clinical Oncology Research, Dublin 4, Ireland. · Division of Pathology, European Institute of Oncology, 20146 Milano, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. · Pubmed 29207087
  • Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Unité de Gestion de l'Information, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Medical Oncology Clinic, Charleroi Universitary Hospital, Université Libre de Bruxelles (U.L.B.), Charleroi, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 30425844
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium. · Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino, Genova, Italy. · Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy. · Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, centre affilié de l'Université de Sherbrooke, Quebec, Canada. · Department I of Internal Medicine, Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino, Department of Internal Medicine and Medical Specialties (DIMI), University of Genova, Genova, Italy. · Pubmed 29942664
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Computational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Center, East Melbourne, Victoria, Australia. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Obstetrics and Gynecology, University of Munich, Munich, Germany. · Novartis AG, Basel, Switzerland. · Department of Oncology, Istituto Nazionale Tumori, Milan, Italy. · Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany. · Breast Medical Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 29902299
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Department of Medical Oncology, Oncologia Medica 2, School of Medicine, University of Genova, Genova, Italy. · Unit of Clinical Epidemiology, School of Medicine, University of Genova, Genova, Italy. · Health Direction, School of Medicine, University of Genova, Genova, Italy. · Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino IRCCS per l'Oncologia, School of Medicine, University of Genova, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29873695
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Medical Oncology Department, Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Département d'hémato-oncologie, CISSS Montérégie-centre/Hôpital Charles-Lemoyne, centre affilié de l'Université de Sherbrooke, Greenfield Park, Qc, Canada. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Pubmed 29474991
  • Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. Electronic address: · Frontier Science (Scotland) Ltd., Kincraig, UK. · Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Brussels, Belgium. · Fondazione IRCCS, Istituto Nazionale Dei Tumori di Milano, Italy. · IRCCS A.O.U. S.Martino-IST, Genoa, Italy. · European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · SOLTI Breast Cancer Research Group, Barcelona, Spain. · Breast International Group (BIG), Brussels, Belgium. · Instituto de Oncologia de Rosário, Rosário, Argentina. · Clinica de Oncologia, Porto Alegre, Brazil. · Queen Elizabeth Hospital, Hong Kong, China. · Istituto Europeo di Oncologia, Milan, Italy. · Ospedale di Trento, Trento, Italy. · Oslo University Hospital, Oslo, Norway. · The Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom. · Ulm University Hospital, Ulm, Germany. · Memorial Sloan Kettering Cancer Center, New York, USA. · Pubmed 29227816
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Department of Breast Surgery, University Hospital Herlev, Copenhagen, Denmark. · Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. · Vall D'Hebron University Hospital, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · Macerata Hospital, Macerata, Italy. · Danish Breast Cancer Group, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group Statistical Centre, Dana-Farber Cancer Institute, Boston, MA. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · European Institute of Oncology, Milan, Italy. · Pubmed 29087485
  • Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Fertility Clinic, CUB-Hôpital Erasme and Research Laboratory on Human Reproduction, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Hospital de Santa Maria and Instituto de Medicina Molecular, Faculdade de Medicina, Universiade de Lisboa, Lisbon, Portugal. · Department of Internal Medicine, American University of Beirut (AUB), Beirut, Lebanon. · Medical Genetics Department, CUB-Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 29045555
2017
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, H4J 1C5, Montreal, Quebec, Canada. · Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Medical Support Team of the Academic Promoting Team (APT), Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), 1, rue Heger-Bordet, 1000 Brussels, Belgium. · Pubmed 28762384
  • Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. · Department of Medical Oncology and IRON/U1245, Centre Henri Becquerel, Rouen, France. · Breast Cancer Translational Research Laboratory. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 28744140
  • a Clinique d'Oncologie Médicale, Institut Jules Bordet , Université Libre de Bruxelles (U.LB) , Brussels , Belgium. · b Département d'hémato-oncologie , CISSS Montérégie centre/Hôpital Charles Lemoyne, centre affilié de l'Université de Sherbrooke , Greenfield Park , Qc , Canada. · c Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn , University of Cologne , Cologne , Germany. · d Breast Cancer Translational Research Laboratory, Institut Jules Bordet , Université Libre de Bruxelles (U.L.B) , Brussels , Belgium. · Pubmed 28697311
  • Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST, Genova, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Medical Oncology, University of Cagliari, Cagliari, Italy. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast International Group (BIG), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus campus, Wilrijk, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: · Pubmed 28525810
  • Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. Electronic address: · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. Electronic address: · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan Campus Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, 4000 Liège, Belgium. · Centre Hospitalier de Luxembourg, 1210 Luxembour, GD Luxembourg, Belgium. · Department of Radiotherapy, CHU Liège, 4000 Liège, Belgium. · Department of Internal Medicine and Oncology, Clinique St-Joseph Espérance, 4000 Liège, Belgium. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, 59100 Prato, Italy. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), 1000 Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles (U.L.B.), Institut Jules Bordet, 1000 Brussels, Belgium. · Pubmed 29096156
  • Hematology/Oncology Department, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Frontier Science (Scotland) Ltd., Kincraig, UK. · Breast Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Radiation Oncology Department, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada. · Novartis Pharma AG, Basel, Switzerland. · National Cancer Institute, Bethesda, MD, USA. · Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Department of Oncology, Division of Cancer, Oslo University Hospital, Oslo, Norway. · Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Medical Oncology Unit, Azienda Istituti Ospitalieri, Cremona, Italy. · Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Case Western Reserve University, Cleveland, OH, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. · Pubmed 28376188
  • Amir Sonnenblick, Hadassah-Hebrew University Medical Center, Jerusalem, Israel · Dominique Agbor-Tarh and Ian Bradbury, Frontier Science, Kingussie, United Kingdom · Serena Di Cosimo Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy · Hatem A. Azim Jr, Martine Piccart-Gebhart and Evandro de Azambuja, Université Libre de Bruxelles · Debora Fumagalli, Breast International Group, Brussels, Belgium · Severine Sarp, Novartis Pharma AG, Basel, Switzerland · Antonio C. Wolff, Johns Hopkins School of Medicine, Baltimore, MD · Lyndsay Harris, Case Western Reserve University School of Medicine, Cleveland, OH · Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA · Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL · Michael Andersson, Rigshospitalet University Hospital Copenhagen, Denmark · Judith Kroep, Leiden University Medical Center, Leiden, the Netherlands · Tanja Cufer, University Clinic Golnik Medical Faculty, Ljubljana, Slovenia · Sergio D. Simon, Hospital Israelita Albert Einstein · Sergio D. Simon, Grupo Brasileiro de Estudos do Cancer de Mama, São Paulo, Brazil · Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile · Masakazu Toi, Kyoto University, Kyoto, Japan · Maccon Keane, University Hospital Galway, Galway · and Maccon Keane, Cancer Trials Ireland, Dublin, Ireland. · Pubmed 28375706
  • University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. Electronic address: · Department of Medicine, Université Libre de Bruxelles, Brussels, Belgium. · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · Frontier Science Scotland Ltd, Kincraig, Kingussie, UK. · European Institute of Oncology, Milan, Italy. · Medical Oncology Clinic, Université Libre de Bruxelles, Brussels, Belgium. · Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. · Helios Klinikum Berlin Buch, Multidisciplinary Breast Cancer Center, Berlin, Germany. · Breast Unit, Royal Marsden Hospital, and The Institute of Cancer Research, London, UK. · Department of Medical Oncology, San Raffaele Hospital, Scientific Institute, Milan, Italy. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Avera Cancer Institute Center for Precision Oncology, Sioux Falls, SD, USA. · Deakin University, Waurn Ponds, VIC, Australia. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Pubmed 28215665
  • Dimitrios Zardavas, Breast International Group · Martine J. Piccart-Gebhart and Evandro de Azambuja, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Thomas M. Suter, Bern University Hospital, Bern · Jutta Steinseifer, Johannes Noe, Sabine Lauer, and Nedal Al-Sakaff, F. Hoffmann-La Roche, Basel, Switzerland · and Dirk J. Van Veldhuisen, University Medical Center Groningen, University of Groningen, The Netherlands. · Pubmed 28199174
  • Breast Data Centre, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Institute for Oncology and Radiology of Serbia, National Cancer Research Centre, Belgrade, Republic of Serbia. · Breast International Group, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Hospital Albert Einstein, São Paulo, Brazil. · Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brusells, Belgium. · Pubmed 28151718
2016
  • Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group (BIG aisbl), Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medigene AG, Planegg, Germany. · Department of Biostatistics, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Univ. Paris-Sud, Villejuif, France. · Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 27454930
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Department of Hematology and Oncology, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J. C. Heuson, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Medical Oncology Clinic, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Data Centre, Institut Jules Bordet/Université libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France. · Pubmed 26931736
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue Yawkey, Boston, 1238, USA. · Department of Medical Oncology and Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science (Scotland) Ltd, Kincraig, Kingussie, UK. · Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Breast Unit, Royal Marsden Hospital, and Institute of Cancer Research, London, UK. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Edinburgh Cancer Research Centre, Western general Hospital, University of Edinburgh, Crewe Road South, Edinburgh, UK. · Department of Gynecology and Obstetrics and Multidisciplinary Breast Cancer Center, Helios Klinikum, Berlin-Buch, Germany. · Department of Gynecology and Obstetrics, Klinikum Off enbach, Off Enbach, Germany. · Department of Medical Oncology, The Andrew Love Cancer Centre, Deakin University, Geelong, Australia. · Department of Medical Oncology, San Raffaele Institute, Milan, Italy. · European Institute of Oncology, Milan, Italy. · Swiss Center for Breast Health, Sant'Anna Clinic, Lugano-Sorengo, Switzerland. · Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Harvard School of Public Health, Harvard Medical School, Boston, USA. · Pubmed 26708471
  • Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK. · Liverpool and Merseyside Academic Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, UK. · The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool, UK. · Department of Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Medical Oncology, Imperial College Healthcare NHS Trust, London, UK. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Clinical Oncology, West Middlesex University Hospital, London, UK. · Department of Clinical Oncology, The Royal United Hospital, Combe Park, Bath, UK. · Ealing Hospital NHS Trust, Middlesex, UK. · Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK. · University of Manchester, Institute of Cancer Sciences, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Pubmed 26334099
2015
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 125, B-1000 Brussels, Belgium. · Pubmed 25286972
  • Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, Hôpital Ambroise Pare, Mons, Belgium. · Neuropsychologue CHIREC, Brussels, Belgium. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cardiology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, CHC-Clinique Saint-Joseph, Liege, Belgium. · Department of Oncology, CHU Tivoli - GOHH, La Louviere, Belgium. · Clinique Ste-Elisabeth, Namur, Belgium. · Department of Oncology, Hôpital de Jolimont, Haine St Paul, Belgium. · Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland. · Pubmed 26321502
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, Melbourne, Australia; Australia and New Zealand Breast Cancer Trials Group Newcastle, Australia; International Breast Cancer Study Group, Bern, Switzerland. · Swedish Breast Cancer Group, Universitetssjukhuset, Linkoping, Sweden. · Grupo Oncologico Cooperativo Chileno De Investigacion, Clinica Las Condes, Santiago, Chile. · International Drug Development Institute, Louvain-La-Neuve, Belgium. · University of Milan School of Medicine, and Department of Pathology, European Institute of Oncology, Milan, Italy. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Department of Oncology, Copenhagen University Hospital Rigshospitalet, and Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. · Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia/INCLIVA, Universidad de Valencia, Spain(1). · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria. · European Institute of Oncology, Milan, Italy; International Breast Cancer Study Group (IBCSG), Bern, Switzerland. · Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Medical Oncology Department, Hospital Santa Creu i Sant Pau, Medicine Department, Universitat Autònoma, Barcelona, Spain(1). · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · St Vincet's University Hospital, Dublin 4, Ireland. Electronic address: · Pubmed 26074397
  • Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · Pubmed 25899784
2014
  • Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles · Dimitrios Zardavas, Breast International Group, Brussels, Belgium · Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia · and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. · Pubmed 25049332
  • Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. · Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, 20133 Milano, Italy. · Department of Medical Oncology, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 24794210
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. · Research Center of Epidemiology, Biostatistics and Clinical Research, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP598, Route de Lennik 808, 1070 Brussels, Belgium. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Department of Medical Oncology, Hirslanden Clinic Aarau, Schänisweg, 5001 Aarau, Switzerland. · Research Center of Social Approaches of Health, School of Public Health, Université Libre de Bruxelles, Campus Erasme - CP 596, Route de Lennik, 808, 1070 Brussels, Belgium. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121 (7th Floor), 1000 Brussels, Belgium. Electronic address: · Pubmed 25446375
  • BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium · BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Frontier Science, Kincraig, Kingussie, Scotland. · Pubmed 25225439
2013
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium ; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Brussels, Belgium. · Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Brussels, Belgium. · Pubmed 24415979
  • Breast Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24013582
  • Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY · James G. Greger Jr, GlaxoSmithKline, Collegeville, PA · Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles · Phuong Dinh, Breast International Group, Brussels · Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium · Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland · Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research, London, United Kingdom · Serena Di Cosimo, IRCCS Fondazione Instituto Nazionale dei Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Christian Jackisch, Kilinikum Offenbach, Offenbach · Bahriye Aktas, Kliniken Essen-Mitte, Evang, Essen · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Sung-Bae Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea · Chiun-Sheng Huang, National Taiwan University Hospital · Ruey Kuen Hsieh, Mackey Memorial Hospital, Taipei, Taiwan · and Lydia Dreosti, University of Pretoria, Pretoria, South Africa. · Pubmed 24248687
2017
  • From the German Breast Group, Neu-Isenburg, Germany (G.M.) · Frontier Science (Scotland), Kincraig, United Kingdom (M. Procter) · the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), and Institut Jules Bordet, Université Libre de Bruxelles (M. Piccart) - all in Brussels · Roche Pharma (M.B., E.C., A.K.) and the Department of Cardiology, Cardio-Oncology, Bern University Hospital (T.S.) - both in Bern, Switzerland · the Department of Pathology, European Institute of Oncology, University of Milan, Milan (G.V.) · the National Institute of Oncology, Budapest, Hungary (I.L.) · Centre François Baclesse, Caen, France (C.L.) · the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.A.Y.) · Instituto Nacional de Câncer, Rio de Janeiro (J. Bines) · Dana-Farber Cancer Institute, Harvard Medical School, Harvard T. H. Chan School of Public Health, and Frontier Science and Technology Research Foundation - all in Boston (R.D.G.) · and the Department of Medicine, Memorial Sloan Kettering Cancer Center, New York (J. Baselga). · Pubmed 28581356
2016
  • Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP). · Department of Medicine, Breast European Adjuvant Study Team (BrEAST) Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium (AS, EdA, MP, HAAJr); Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, UK (DAt, IB, CC); Novartis Pharmaceuticals Corporation, East Hanover, NJ (YH); Alliance Statistics and Data Center, Mayo Clinic, Section of Biostatistics, Scottsdale, AZ (ACD); Sunnybrook Odette Cancer Centre, the University of Toronto and the NCIC Clinical Trials Group, Toronto, Ontario, Canada (KIP); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD (ACW); Sana Klinikum Offenbach, Offenbach, Germany (CJ); National Institute of Oncology, Budapest, Hungary (IL); Helios Klinikum Berlin-Buch, Berlin, Germany (MU); Royal Marsden Hospital NHS Trust, Sutton/Surrey, UK (IS); Patricia Ritchie Centre for Cancer Care and Research, The University of Sydney, Mater Hospital, North Sydney, Australia (FB); Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China (BX); Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru (HG); Mayo Clinic, Jacksonville, FL (EAP) · Pubmed 27098150
2013
  • Medicine Department, Institut Jules Bordet, Université libre de Bruxelles, Boulevard de Waterloo, 125, 1000 Brussels, Belgium; Br.E.A.S.T. Data Centre, Institut Jules Bordet, Boulevard de Waterloo, 121 (7th floor), 1000 Brussels, Belgium. · Pubmed 24074778
  • Breast Cancer Translational Research Laboratory, J.C. Heuson, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium; Department of Medicine, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24060577
  • Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23990869
  • Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 24092940
  • Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels. · Pubmed 24078620
  • Breast International Group, Brussels, Belgium; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23643661
Unspecified
2019
  • Department of Medicine. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Pubmed 30299291
  • Academic Trials Promoting Team. · Medical Oncology Department, Institut Jules Bordet. · Pubmed 31859350
2014
  • Evandro de Azambuja and Martine J. Piccart-Genhart, Institut Jules Bordet · Evandro de Azambuja, Breast European Adjuvant Study Team · Martine J. Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Marion J. Procter and Dominique Agbor-Tarh, Frontier Science Scotland, Kincraig, Kingussie · David A. Cameron, University of Edinburgh and Western General Hospital, Edinburgh · Ian E. Smith, Royal Marsden Hospital and the Institute of Cancer Research · Mitch Dowsett, the Royal Marsden National Health Service Trust, London, United Kingdom · Dirk J. van Veldhuisen, University of Groningen, Groningen, the Netherlands · Otto Metzger-Filho and Richard D. Gelber, Dana-Farber Cancer Institute, Boston, MA · Jutta Steinseifer, F. Hoffmann-La Roche, Basel · Thomas M. Suter, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland · Michael Untch, HELIOS Klinikum Berlin, Buch · Christian Jackisch, Klinikum Offenbach, Offenbach, Germany · Luca Gianni, San Raffaele Institute, Milan, Italy · Jose Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Richard Bell, Andrew Love Cancer Centre, Geelong Hospital, Geelong, Australia · and Brian Leyland-Jones, Edith Sanford Breast Cancer Research Institute, Sioux Falls, SD. · Pubmed 24912899
Miscellaneous institutions in Brussels
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
28 Other Locations Show
Yearly article counts 52319141191019000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.